Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported)
|
May
9, 2007
|
Interleukin
Genetics,
Inc.
|
(Exact
Name of Registrant as Specified in Its
Charter)
|
|
Delaware
|
(State
or Other Jurisdiction of
Incorporation)
|
001-32715
|
94-3123681
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
|
135
Beaver Street Waltham,
MA
|
02452
|
(Address
of Principal Executive
Offices)
|
(Zip
Code)
|
|
|
(781)
398-0700
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
|
(Former
Name or Former Address, if Changed Since
Last Report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02 Results of Operations and Financial Condition.
On
May 9,
2007, Interleukin Genetics, Inc. issued a press release to report its
consolidated financial results for its first quarter ended March 31, 2007.
A
copy of the earnings press release is being furnished pursuant to this Item
2.02
as Exhibit 99.1 to this Current Report on Form 8-K.
Item
9.01 Financial Statements and Exhibits.
(c)
The
following exhibit is furnished with this report:
Exhibit
No.
|
Description
|
99.1
|
Earnings
Press Release dated May 9,
2007.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
|
Interleukin
Genetics, Inc.
(Registrant)
|
Date:
May 10, 2007 |
|
/s/ Timothy
J. Richerson |
|
Timothy
J. Richerson |
|
Chief
Executive Officer |